U.S. Markets closed
  • S&P 500

    3,638.35
    +8.70 (+0.24%)
     
  • Dow 30

    29,910.37
    +37.90 (+0.13%)
     
  • Nasdaq

    12,205.85
    +111.44 (+0.92%)
     
  • Russell 2000

    1,855.27
    +10.25 (+0.56%)
     
  • Crude Oil

    45.53
    -0.18 (-0.39%)
     
  • Gold

    1,788.10
    -23.10 (-1.28%)
     
  • Silver

    22.64
    -0.81 (-3.44%)
     
  • EUR/USD

    1.1970
    +0.0057 (+0.4788%)
     
  • 10-Yr Bond

    0.8420
    -0.0360 (-4.10%)
     
  • Vix

    20.84
    -0.41 (-1.93%)
     
  • GBP/USD

    1.3314
    -0.0042 (-0.3169%)
     
  • USD/JPY

    104.0850
    -0.1650 (-0.1583%)
     
  • BTC-USD

    17,770.33
    +584.98 (+3.40%)
     
  • CMC Crypto 200

    333.27
    -4.23 (-1.25%)
     
  • FTSE 100

    6,367.58
    +4.65 (+0.07%)
     
  • Nikkei 225

    26,644.71
    +107.40 (+0.40%)
     

Masimo: Q3 Earnings Insights

Benzinga Insights
·1 min read

Shares of Masimo (NASDAQ:MASI) were unchanged after the company reported Q3 results.

Quarterly Results

Earnings per share rose 5.26% over the past year to $0.80, which beat the estimate of $0.62.

Revenue of $278,112,000 higher by 21.44% year over year, which beat the estimate of $256,580,000.

Looking Ahead

Masimo Sees FY20 Adj. EPS $3.46 vs $3.17 Estimate, Sales $1.128B vs $1.09B Est.

Details Of The Call

Date: Oct 27, 2020

Time: 04:30 PM

View more earnings on MASI

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Finvestor.masimo.com%2F&eventid=2628642&sessionid=1&key=8CFB659E9AFC8455BD0D10B8496533BF&regTag=&sourcepage=register

Recent Stock Performance

Company's 52-week high was at $258.00

Company's 52-week low was at $140.53

Price action over last quarter: Up 14.66%

Company Description

Masimo is an Irvine, California-based medical device business that focuses on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue globally, with the United States the largest market (68% of 2019 sales), followed by Europe, the Middle East, and Africa (20%), Asia and Australia (9%), and North and South America excluding the U.S. (3%).

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.